{
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1299, 
        1322
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1788, 
        1808
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1385, 
        1412
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1745, 
        1746
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1768, 
        1769
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1429, 
        1431
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1561, 
        1563
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        572, 
        601
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1635, 
        1670
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1712, 
        1738
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1414, 
        1415
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1546, 
        1547
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1740, 
        1741
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1763, 
        1764
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1053014^CLIA|eMARCPlus|TN Cancer Registry|20170919125825||ORU^R01^ORU_R01|201709191258250001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-21-008329^PathSys^44D1053014^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170817000000|||||||20170817000000|&Core Biopsy Mass, Core Biopsy Mass|1801973490^^^^^^MD^^CMS^D^^^NPI||||||20170818000000|||F||||||C34.90^Malignant neoplasm of unspecified part of unspecified bronchus or lung^I10~J85.0^Gangrene and necrosis of lung^I10|1821206962&&&E.&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\n1. The specimen is received in formalin labeled \", core biopsy\" and consists of multiple pale white-tan, friable fragments of soft tissue measuring 1.0 x 0.3 x 0.1 cm. The specimen is filtered and entirely submitted in cassette 1A, M/1A. 2. The specimen is received in formalin labeled \", core biopsy\" and consists of 2 red-brown, fine, friable core biopsies measuring 0.6 and 1.6 cm in length and less than 0.1 cm each in diameter. Entirely submitted in cassette 2A, 2/2A. Also received in the specimen container is an aggregate of red-brown, friable fragments of soft tissue measuring 1.5 x 1.0 x 0.1 cm. The remainder of the specimen is filtered and entirely submitted in cassette 2B, M/2B.\n\n\nPath report.relevant Hx\n\nHistory - Lung cancer, tumor for study (no work up needed)\n\n\nPath report.final diagnosis\n\n1. Lymph node, 2L, FNA core needle biopsy:     Rare viable tumor cells with predominantly necrosis.     Cartilage.     See comment. 2. Lymph node, 4L, FNA:     Degenerate tumor fragments with necrosis.     See comment.\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.site of origin\n\n1. 2 L FNA core needle 2. 4 L FNA core needle\n\n\nPath report.comments\n\nComments - 1, 2. Material is most abundant in paraffin block 2B. The patient's history of non- small cell carcinoma status post therapy is noted. With the necrosis, therapy effect, and degenerated features within the tumor sampled, characterization is best assessed on previous specimens.\n\n\n"
}